Enable Injections
PrivateLast Round
Strategic
Jan 6, 2026
Est. Valuation
$930M
Total Funding Raised
$350M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enable Injections is a medical device company that develops and manufactures wearable drug delivery systems for the subcutaneous self-administration of high-volume therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enable Injections Comparables
Compare Enable Injections with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nemera | 89% | |
| LTS Lohmann Therapie-Systeme AG | 89% | |
| Ypsomed Holding AG | 84% | |
Enable Injections Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 6, 2026 | ||||
| Series C | Jan 27, 2022 | ||||
| Debt | Sep 8, 2020 | ||||
| Series B | Oct 25, 2018 | ||||
| Series A | Oct 5, 2016 |
Key People
Founding team and executive leadership
Matthew Huddleston
Executive Vice President Chief Technology Officer, Chief Commercial Officer
Enable Injections Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetar Capital | Series C |
| Partisan Management Group | Series B |
| Squarepoint Ventures | Series C |
| CincyTech | Seed, Series A, Series B, Series C |
| GCM Grosvenor | Series C |
| ORI Capital | Series B, Series A |
| Oxford Finance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Developing a digital companion solution for enFuse with Aptar Digital Health.
- Apr 9, 2026
Partnering with Aptar Digital Health on a digital companion solution.
Enable Injections Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enable Injections's valuation, stock price, and market status.